329 related articles for article (PubMed ID: 20181361)
1. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
4. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
5. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
9. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Volz HP; Murck H; Kasper S; Möller HJ
Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
[TBL] [Abstract][Full Text] [Related]
10. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
11. St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
[TBL] [Abstract][Full Text] [Related]
12. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
13. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
Kasper S; Dienel A
Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
[TBL] [Abstract][Full Text] [Related]
14. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine.
Harrer G; Schmidt U; Kuhn U; Biller A
Arzneimittelforschung; 1999 Apr; 49(4):289-96. PubMed ID: 10337446
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
18. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
Singer A; Schmidt M; Hauke W; Stade K
Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
[TBL] [Abstract][Full Text] [Related]
19. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
Sarris J; Fava M; Schweitzer I; Mischoulon D
Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
